ConductScience.org, home

Paper17536871

Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Lenoir G and 7 others. Paediatr Drugs, 2007. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Papers, record 17536871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17536871

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.
PubMed
Journal
Paediatr Drugs
PubMed
Year
2007
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2018-11-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lenoir GGerard
2Antypkin YGYuriy Genadievich
3Miano AAngelo
4Moretti PPaolo
5Zanda MMaurizio
6Varoli GGuido
7Monici Preti PAPier Alessandro
8Aryayev NLNikolay Leonidovich

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Cystic FibrosisMajor topic
Pseudomonas InfectionsMajor topic
TobramycinMajor topic
Administration, Inhalation
Adolescent
Adult
Child
Double-Blind Method
Female
Humans
Male
Nebulizers and Vaporizers
Prospective Studies
Pseudomonas aeruginosa
Treatment Outcome

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18575589Inhalation of antibiotics in cystic fibrosis.Eur Respir J1995https://conductscience.org/library/papers/8575589PubMed
23117701Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.Infection1987https://conductscience.org/library/papers/3117701PubMed
38497284Efficacy of aerosolized tobramycin in patients with cystic fibrosis.N Engl J Med1993https://conductscience.org/library/papers/8497284PubMed
42109790Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.J Pediatr1990https://conductscience.org/library/papers/2109790PubMed
517536870Clinical pharmacology study of Bramitob, a tobramycin solution for nebulization, in comparison with Tobi.Paediatr Drugs2007https://conductscience.org/library/papers/17536870PubMed
62816859Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.Am J Dis Child1989https://conductscience.org/library/papers/2816859PubMed
712091173Spirometry in 3- to 6-year-old children with cystic fibrosis.Am J Respir Crit Care Med2002https://conductscience.org/library/papers/12091173PubMed
812527599Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system.Chest2003https://conductscience.org/library/papers/12527599PubMed
912480612Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.Am J Respir Crit Care Med2003https://conductscience.org/library/papers/12480612PubMed
1015463837Inhaled antibiotic therapy in evidence: what delivery device?J Cyst Fibros2002https://conductscience.org/library/papers/15463837PubMed
1112358344A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.Eur Respir J2002https://conductscience.org/library/papers/12358344PubMed
129041399Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.J Clin Microbiol1997https://conductscience.org/library/papers/9041399PubMed
131539140Use of induced sputum cell counts to investigate airway inflammation in asthma.Thorax1992https://conductscience.org/library/papers/1539140PubMed
1410536249Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.Int J Pharm1999https://conductscience.org/library/papers/10536249PubMed
156859656Changes in the normal maximal expiratory flow-volume curve with growth and aging.Am Rev Respir Dis1983https://conductscience.org/library/papers/6859656PubMed
161549817Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.Thorax1992https://conductscience.org/library/papers/1549817PubMed
1711129122The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?Drugs2000https://conductscience.org/library/papers/11129122PubMed
187481201Biostatistical methodology in clinical trials--a European guideline.Stat Med1995https://conductscience.org/library/papers/7481201PubMed
1911796432Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis.Chest2002https://conductscience.org/library/papers/11796432PubMed
209878641Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.N Engl J Med1999https://conductscience.org/library/papers/9878641PubMed

See all 28 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
40223951
Comparative efficacy and safety of inhaled antibiotics in managing chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis and bronchiectasis: a systematic review and network meta-analysis.
J Thorac Dis2025https://conductscience.org/library/papers/40223951PubMed
40001409Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review.Antibiotics (Basel)2025https://conductscience.org/library/papers/40001409PubMed
39648822
Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical Trials and Cohort Studies.
J Aerosol Med Pulm Drug Deliv2025https://conductscience.org/library/papers/39648822PubMed
37268599Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/37268599PubMed
37194817
Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association).
J Bras Pneumol2023https://conductscience.org/library/papers/37194817PubMed
36978351Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis.Antibiotics (Basel)2023https://conductscience.org/library/papers/36978351PubMed
36373968Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36373968PubMed
35914011Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/35914011PubMed
34438986Therapeutic Approach of Chronic Pseudomonas Infection in Cystic Fibrosis-A Network Meta-Analysis.Antibiotics (Basel)2021https://conductscience.org/library/papers/34438986PubMed
33486720Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions.Clin Pharmacokinet2021https://conductscience.org/library/papers/33486720PubMed
30376155Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/30376155PubMed
30288426Shared Decision-Making Tool for Self-Management of Home Therapies for Patients With Cystic Fibrosis.MDM Policy Pract2017https://conductscience.org/library/papers/30288426PubMed
29607494Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29607494PubMed
28440853Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28440853PubMed
25792839Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.Ther Clin Risk Manag2015https://conductscience.org/library/papers/25792839PubMed
25278817Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.Core Evid2014https://conductscience.org/library/papers/25278817PubMed
25278574Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Clin Microbiol Rev2014https://conductscience.org/library/papers/25278574PubMed
24489509Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis.ScientificWorldJournal2013https://conductscience.org/library/papers/24489509PubMed
24476418Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis.Ann Am Thorac Soc2014https://conductscience.org/library/papers/24476418PubMed
22915944Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review.Med Devices (Auckl)2011https://conductscience.org/library/papers/22915944PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17536871

GET https://conductscience.org/api/papers/v1/17536871/references?page=2